The largest database of trusted experimental protocols

29 protocols using anti tgf β

1

Isolation and Differentiation of Treg and Tfh Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated from peripheral blood using Ficoll density-gradient centrifugation. Treg cells were obtained as CD4+CD25T cell subsets, and naïve CD4+ T cells were isolated and purified using a naïve CD4+ T cell isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions. Then, CD4+CD25 T cells (1 × 106/well) were cultured with soluble anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) antibodies, with the addition of recombinant human TGF-β1 (10 ng/ml; R&D Systems, USA) and IL-2 (100 U/ml; Peprotech, USA) to induce Treg cell conversion. After culturing for 5–6 days, the cells were collected for the measurement of CD4+CD25+ percentages by flow cytometry.
Tfh cells were obtained as naive CD4+ T cells (1 × 106/well) and stimulated with soluble anti-CD3 (1 μg/ml) and anti-CD28 (1 μg/ml) antibodies, with the addition of recombinant human IL-2 (100 U/ml; Peprotech, USA), IL-6 (20 ng/ml; Peprotech, USA), anti-IL-4 (10 μg/ml; R&D Systems, USA), anti-IFN-γ (10 μg/ml; R&D Systems, USA) and anti-TGF-β (10 μg/ml; R&D Systems, USA). After 5–6 days, the cells were collected for the measurement of CXCR5++PD-1++CD4+ T cell or CXCR5+ +PD-1++ Foxp3+CD4+ T cell percentages by flow cytometry.
+ Open protocol
+ Expand
2

Murine Naive CD4+ T Cell Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen and lymph nodes from mice were harvested, mechanically disrupted, and passed through a 70-μm filter. Naive CD4+ T cells from the sample were purified by magnetic bead separation using the CD4+CD62L+ isolation kit (Miltenyi Biotec). Cells were plated in 96-well plates coated with anti-CD3 antibody (5 μg/mL, BD, clone 145-2C11) at a density of 3 × 106 cells/mL. Cells were plated in Tfh-conditioning media (RPMI complete media with 10% fetal bovine serum), 10 μg/mL anti-IL4 (BD Biosciences, clone 11B11), 10 μg/mL anti-IFNγ (BD Biosciences, clone XMG1.2), 10 μg/mL anti-TGFβ (R&D Systems, clone 1D11), 30 ng/mL IL6 (Shenandoah Biotechnology), and 50 ng/mL IL21 (Shenandoah Biotechnology) in the presence of soluble anti-CD28 (2 μg/mL, BD, clone 37.51). Polarized cells were harvested for Tfh phenotyping by flow cytometric analysis 4 days after plating.
For surface phenotype and transcription factor analysis, harvested cells were stained with Live/Dead Fixable Aqua dead cell stain (Thermo Scientific Fisher) to exclude dead cells. Cells were subsequently stained for surface markers (CD4, TCRβ, PD1, CXCR5) and then fixed and permeabilized using the Intracellular Fixation and Permeabilization Buffer Set (eBioscience). Fixed cells were stained with antibody to BLC6 (clone 7D1) or isotype control.
+ Open protocol
+ Expand
3

Isolation and Stimulation of T Cells with Vitamin D and TGF-β

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cells (PBMCs) were isolated, as previously described Xystrakis et al. (31 (link)). CD4+ and CD8+ T cells were isolated using Dynabeads CD4 or CD8 positive selection kits (Invitrogen, Paisley, UK). Cells (1 × 106/ml) were cultured in RPMI 1640 medium supplemented with 10% FCS, 2 mM L-glutamine, and 50 μg/ml gentamicin, and stimulated with plate-bound anti-CD3 (1 μg/ml; OKT3) plus 50 IU/ml recombinant human IL-2 (Eurocetus, UK) in the presence or absence of 1,25(OH)2D3 (BIOMOL research labs, UK), TGF-β1 (R&D Systems, UK), TGF-β2 (R&D Systems) or anti-TGF-β (R&D Systems) at indicated concentrations for 7 days. NIST SRM1648a Urban Particulate Matter (National Institute of Standards & Technology, USA) is an urban total particulate matter reference material with mean particle diameter 5.85 μm, collected in the USA. NIST was prepared as previously described by Pfeffer et al. (32 (link)).
+ Open protocol
+ Expand
4

Blocking Cytokines and Checkpoint Inhibitors in T-cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were thawed, washed and reconstituted in AIM V serum-free medium (Life Technologies, Oslo, Norway) containing 0.1% human serum albumin. After an overnight rest, cells were pulse-labelled with carboxyfluorescein diacetate succinimidyl ester (CFSE, Life Technologies) at a concentration of 2 μM for 5 minutes. The following blocking antibodies were added to parallel culture wells at a final concentration of 10 μg/mL: anti-IL-10 (R&D Systems, MN, USA; clone 23738), anti-TGF-β (R&D; clone 1D11), anti-PD-L1 (eBioscience, CA, USA; clone MIH1), and anti-HVEM (R&D; clone 94801).
After a 30 minute incubation, cultures were stimulated with either Gag or Env 15-mer overlapping peptide panels (NIH AIDS Research and Reference Reagent Program, MD, USA) at a final concentration of 2 μg/mL/peptide. Staphylococcal Enterotoxin B (SEB, Sigma-Aldrich, MO, USA) at a final concentration of 0.5 μg/mL was used as a positive control.
Cells were cultured at 37°C in 5% CO2 for 5 days, harvested, and stained with the following fluorochrome-conjugated antibodies: CD3 V450, CD8 APC-H7, HLA-DR BV605, CD45RA APC (all BD) and CD25 PE (Biolegend). 7-aminoactinomycin D (7-AAD, BD) was added for dead cell exclusion. Flow cytometry data were acquired on a BD FACS Canto II with BD Diva 6.1 software, and analyzed in FlowJo X (FlowJo LLC, OR, USA).
+ Open protocol
+ Expand
5

Whole Blood Antigen Response Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood cell cultures were performed to determine the in vitro responses to antigens. Briefly, whole blood was diluted 1:1 with RPMI1640 medium supplemented with penicillin/streptomycin (100 U/100 mg/ml), L-glutamine (2 mM), and HEPES (10 mM; all from Invitrogen) and distributed in 12-well tissue culture plates (Costar). The cultures were then stimulated with ESAT-6, CFP-10, or anti-CD3 or with medium alone in the presence of CD49d/CD28 at 37°C for 18 h. Brefeldin A (10 µg/mL) was added after 12 h. After 18 h, centrifugation, washing, and red blood cell lysis was performed. The cells were fixed using cytofix/cytoperm buffer (BD Biosciences, San Jose, CA) and stored at −80°C. For neutralization experiments, whole blood was cultured in the presence of anti-IL-27 (5 μg/ml), anti-TGFβ (5 μg/ml) (R&D Systems, Minneapolis, MN), anti-PDL-1 (5 μg/ml) (eBiosciences, San Diego, CA), and anti CLTA-4 (5 μg/ml) (Ancell), or isotype control antibody (5 μg/ml) (R&D Systems) at 37°C for 6 h following which PPD was added and Brefeldin A (10 µg/ml) was added after 1 h. The cells were then cultured for a further 16 h.
+ Open protocol
+ Expand
6

Analyzing B-cell Suppression of CD8+ T-cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T cells were isolated from spleens of naïve mice using EasySep™ Mouse CD8+ T-Cell Isolation Kit (StemCell Technologies,). Cells were labeled with the eBioscience™ cell proliferation dye eFluor 450 (Thermo Fischer). To test B-cell ability to suppress activated CD8+ T-cell proliferation, cells were mixed at 1:1 B: T ratio. CD8+ T-cell activation was assessed using the anti-CD3/CD28 T-cell activating beads used at 1:3 beads:CD8+ T-cell ration (Invitrogen, Thermo Fischer) plus IL2 (50 U/mL, Peprotech) for 3 days in complete RPMI. T-cell proliferation (eFluor450 dye dilution) and effector T-cell factors such as granzyme B and IFNγ (Supplementary Table S1) were analyzed by flow cytometry. Anti-IL10 (Thermo Fischer), anti-TGFβ (R&D), anti-TIGIT (BioLegend), and anti–PD-L1 (BioXcell) were added every day in the culture at 10 μg/mL. Alternatively, expression of TGFβ (LAP), IL10, and IFNγ by B cells while cocultured with CD8+ T-cells was examined after 36 hours (Supplementary Table S4).
+ Open protocol
+ Expand
7

Exosome Surface Protein Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For detecting exosome-associated surface proteins, on-bead flow cytometry was performed following exosome capture on streptavidin magnetic beads coated with biotin- labeled anti-CD63 mAbs. The detailed protocol was previously reported [47 (link)]. The following labeled detection Abs were used for staining: anti-E-cadherin (Biolegend, # 324104), anti-N-cadherin (Biolegend # 350808) or and anti-TGF-β (R&D, # FAB2463P). Immediately following 1h staining with Abs at RT and washing with buffer, flow cytometry was performed using a Gallios instrument. Samples were run for 2min and 10,000 events were acquired. For each detection Ab, corresponding isotype controls were included.
+ Open protocol
+ Expand
8

Investigating MenSCs' Immunomodulatory Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the effects of MenSCs on CD4 + T cells proliferation, CD4 + T cells were co-cultured in different settings as mentioned above. Before co-culturing, CD4 + T cells were washed and labeled with 5 μM 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, USA).
To investigate the effects of MenSCs secretome on CD4 + T cell proliferation, a transwell system (Corning, USA) was utilized. Briefly, IFN-γ/IL-1β-treated MenSCs were seeded in the lower chamber of a 24-well transwell plate. Later, CD4 + T cells were added into the upper chamber and plates were incubated for five days in incubator. In some settings, 1 mM 1-Methyl-DL-tryptophan (Sigma, USA) as IDO blocker, 20 mM Indomethacin (Sigma, USA) as PGE2 inhibitor, 10 µg/mL anti-IL-6 antibody (R&D systems, USA), 10 µg/mL anti-IL10 antibody (R&D systems, USA) or 10 µg/mL anti-TGF-β (R&D systems, USA) were added to the co-cultures in order to investigate the involvement of aforesaid molecules on modulatory effects of MenSCs on T cell proliferation or Treg generation. After 5 days, proliferation of CD4 + T cells and frequency of Tregs were assessed by flow cytometry.
+ Open protocol
+ Expand
9

TGF-β and Cytokine Modulation of BrC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrC cells were plated at a density of 3×105 cells/ml/well in 6-well flat bottom culture plates. Once cells attached to the plate, supernatants were discarded, cells were rinsed with PBS 1X, and then cultured with 3 ml of conditioned media or with their respective media supplemented with 5, 10 or 20 ng/ml of human recombinant TGF-β (ref. 100-21) or 100 ng/ml of the following cytokines: G-CSF (ref. 300-23), GM-CSF (ref. 300-03), IL-8 (ref. 200-08) and MCP-1 (ref. 300-04) (all cytokines were from PeproTech) individually or all combined in a cocktail of cytokines. After incubation for 72 h cells were harvested for analyses. To neutralize the biological activity of TGF-β of the HA-CMs, 2 µg/ml of the rabbit anti-human TGF-β1, anti-β2, and anti-β3 neutralizing antibody (anti-TGF-β, R&D Systems, Inc., ref. MAB1835) were added according to the guideline provided by the manufacturer.
+ Open protocol
+ Expand
10

Comprehensive Cytokine Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brefeldin A (1:1000, eBioscience) was added to block cytokine secretion after harvesting cells from tissue. Labeling of dead cells, fixation, and permeabilization were performed as described in the manufacturer’s protocol. Depending upon the experiment, cells were surface stained with anti-CD4-APC-Cy7 or pacific blue (eBioscience, Biolegend), anti-B220, anti-CD8 and a lineage stain (NK1.1, CD11b, TCRγδ, and CD11c; eBioscience, Biolegend) for 30 minutes at 4 °C and following permeabilization, with anti-IL-2-PE-Cy7 (JES6-5H4; eBioscience), anti-IL-4-PE-Cy7 (11B11; BD Bioscience), anti-IL-6-PE (MP5-20F3; eBioscience), anti-TNFα-PE-Cy7 (TN3-19.12; eBioscience), anti-IFNγ-PE-Cy7 (XMG1.2; Biolegend), anti-TGF-β (R&D) for 30 minutes at room temperature. Cells were finally resuspended in 250 μL 1% BSA/PBS and filtered prior to acquisition on a FACS Canto II flow cytometer (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!